Mdig shapes 3D chromatin architecture of immune checkpoint genes and limits metastasis of triple negative breast cancer cells

Authors:
  • ZWZiwei Wang
    Ziwei Wang
  • ZLZiqi Liu
    Ziqi Liu
  • CTChitra Thakur
    Chitra Thakur
  • YQYiran Qiu
    Yiran Qiu
  • JWJun Wang
    Jun Wang
  • MDMehdi Damaghi
    Mehdi Damaghi
  • JHJohn D Haley
    John D Haley
  • FCFei Chen
    Fei Chen

Abstract
Despite decades of progress in metastasis research, the identity of bona fide metastasis-driving genes remains elusive. By shifting the focus from individual genes to the three-dimensional (3D) architecture of the genome, we identify the mineral dust-induced gene (mdig) as a chromatin-topology regulator that suppresses immune-checkpoint activation and metastasis in triple-negative breast cancer (TNBC). Re-expression of mdig in mdig-knockout (KO) cells markedly reduced liver metastasis, whereas mdig loss activated epithelial-mesenchymal transition (EMT), T-cell exhaustion, and antigen-presentation pathways. Across multiple cancer types, high mdig expression predicted improved responses to immune checkpoint blockade (ICB). Mechanistically, mdig depletion derepressed inhibitory checkpoint genes, including PD-L1, PD-L2, LGALS9, and PLXNB1/2, accompanied by increased H3K9me3 and H3K36me3 at these loci. Hi-C profiling revealed that mdig maintains topologically associating domains (TADs) and long-range repressive loops at checkpoint loci; loss of mdig disrupted these structures, enabling coordinated activation of immune-evasion programs. Genome-wide analyses showed extensive TAD remodeling in mdig KO cells, with pronounced alterations on chromosome X. Collectively, these findings position mdig as a key chromatin-architectural regulator of immune evasion and metastatic behavior, underscoring its potential as a biomarker for ICB responsiveness in TNBC and beyond.
Funding Information
  • National Institutes of Health (NIH) (R01 ES031822, R01 ES028335, R01 ES028263)
  • Research Start-up fund of the Stony Brook University
  • Baldwin Breast Cancer Research foundation
  • American Cancer Society